Patient data from GP surgeries sold to US companies Dealings with international pharma raise new fears about American ambitions to access NHS
Data about millions of NHS patients has been sold to US and other international pharmaceutical companies for research, the Observer has learnt, raising new fears about America’s growing ambitions to access lucrative parts of the health service after Brexit.
US drugs giants, including Merck, Bristol-Myers Squibb and Eli Lilly, have paid the Department of Health and Social Care, which holds data derived from GPs’ surgeries, for licences costing up to £330,000 each in return for anonymised data to be used for research. The Guardian
See also:
Data about millions of NHS patients has been sold to US and other international pharmaceutical companies for research, the Observer has learnt, raising new fears about America’s growing ambitions to access lucrative parts of the health service after Brexit.
US drugs giants, including Merck, Bristol-Myers Squibb and Eli Lilly, have paid the Department of Health and Social Care, which holds data derived from GPs’ surgeries, for licences costing up to £330,000 each in return for anonymised data to be used for research. The Guardian
See also:
No comments:
Post a Comment